136 related articles for article (PubMed ID: 8709166)
21. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
[TBL] [Abstract][Full Text] [Related]
22. [Antigenicity studies of prulifloxacin (NM441)].
Tateda C; Sakai K; Yamakawa S; Nakasuji T; Nakamura T; Sumi N; Shindo Y
J Toxicol Sci; 1996 Jun; 21 Suppl 1():231-9. PubMed ID: 8709164
[TBL] [Abstract][Full Text] [Related]
23. Photoallergenicity of a fluoroquinolone antibacterial agent with a fluorine substituent at the 8-position in guinea pigs exposed to long-wavelength UV light.
Marutani K; Otabe Y; Nagamuta M; Matsubara S; Otani H
Skin Pharmacol Appl Skin Physiol; 1998; 11(4-5):232-40. PubMed ID: 9885407
[TBL] [Abstract][Full Text] [Related]
24. [Clinical study of prulifloxacin on infectious enteritis. Japan Research Committee of Prulifloxacin, Research Group on Infectious Enteritis].
Tomizawa I; Takizawa Y; Nitta Y; Tsunoda T; Fukuda H; Yamaguchi T; Masuda G; Negishi M; Ajisawa A; Murata M; Ohnishi K; Irimajiri S; Obana M; Sajima Y; Sagara H; Kato H; Hosoda S; Banba T; Sasaki M; Yoshikawa K; Nakagawa M; Ohkubo H; Kim Y; Akao M; Fukuyama M
Kansenshogaku Zasshi; 1996 Jul; 70(7):727-45. PubMed ID: 8797308
[TBL] [Abstract][Full Text] [Related]
25. [Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
Fukuda H; Kawamura Y
Jpn J Antibiot; 2002 Jun; 55(3):270-80. PubMed ID: 12199111
[TBL] [Abstract][Full Text] [Related]
26. Quinolone antibacterial-agent-induced cutaneous phototoxicity: ear swelling reactions in Balb/c mice.
Wagai N; Tawara K
Toxicol Lett; 1991 Oct; 58(2):215-23. PubMed ID: 1949080
[TBL] [Abstract][Full Text] [Related]
27. Lymphocyte stimulation test with drug-photomodified cells in patients with quinolone photosensitivity.
Tokura Y; Seo N; Ohshima A; Yagi H; Furukawa F; Takigawa M
J Dermatol Sci; 1999 Sep; 21(1):34-41. PubMed ID: 10468190
[TBL] [Abstract][Full Text] [Related]
28. Possible relationship between phototoxicity and photodegradation of sitafloxacin, a quinolone antibacterial agent, in the auricular skin of albino mice.
Shimoda K; Ikeda T; Okawara S; Kato M
Toxicol Sci; 2000 Aug; 56(2):290-6. PubMed ID: 10910986
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):285-92. PubMed ID: 9105547
[TBL] [Abstract][Full Text] [Related]
30. Fluoroquinolone antibacterials enhance UVA-induced skin tumors.
Klecak G; Urbach F; Urwyler H
J Photochem Photobiol B; 1997 Feb; 37(3):174-81. PubMed ID: 9085564
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of photosensitising ability of quinolones in guinea-pigs.
Horio T; Kamada K; Ogawa A; Inoue T; Ishihara M
Drugs; 1995; 49 Suppl 2():283-5. PubMed ID: 8549333
[No Abstract] [Full Text] [Related]
32. Apoptotic photoreceptor cell death induced by quinolone phototoxicity in mice.
Shimoda K; Kato M
Toxicol Lett; 1999 Mar; 105(1):9-15. PubMed ID: 10092051
[TBL] [Abstract][Full Text] [Related]
33. Compare two methods of measuring DNA damage induced by photogenotoxicity of fluoroquinolones.
Zhang T; Li JL; Xin J; Ma XC; Tu ZH
Acta Pharmacol Sin; 2004 Feb; 25(2):171-5. PubMed ID: 14769204
[TBL] [Abstract][Full Text] [Related]
34. The photocarcinogenesis of antibiotic lomefloxacin and UVA radiation is enhanced in xeroderma pigmentosum group A gene-deficient mice.
Itoh T; Miyauchi-Hashimoto H; Sugihara A; Tanaka K; Horio T
J Invest Dermatol; 2005 Sep; 125(3):554-9. PubMed ID: 16117798
[TBL] [Abstract][Full Text] [Related]
35. In vivo evaluation of NM441, a new thiazeto-quinoline derivative.
Ozaki M; Matsuda M; Tomii Y; Kimura K; Segawa J; Kitano M; Kise M; Shibata K; Otsuki M; Nishino T
Antimicrob Agents Chemother; 1991 Dec; 35(12):2496-9. PubMed ID: 1667252
[TBL] [Abstract][Full Text] [Related]
36. Reduced phototoxicity of a fluoroquinolone antibacterial agent with a methoxy group at the 8 position in mice irradiated with long-wavelength UV light.
Marutani K; Matsumoto M; Otabe Y; Nagamuta M; Tanaka K; Miyoshi A; Hasegawa T; Nagano H; Matsubara S; Kamide R
Antimicrob Agents Chemother; 1993 Oct; 37(10):2217-23. PubMed ID: 8257147
[TBL] [Abstract][Full Text] [Related]
37. Phototoxic lesions induced by quinolone antibacterial agents in auricular skin and retina of albino mice.
Shimoda K; Yoshida M; Wagai N; Takayama S; Kato M
Toxicol Pathol; 1993; 21(6):554-61. PubMed ID: 8052802
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of prulifloxacin. 3rd communication: metabolism in rats, dogs and monkeys.
Okuyama Y; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):293-8. PubMed ID: 9105548
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of the repeat dose toxicity of grepafloxacin and a number of other fluoroquinolones in rats.
Takizawa T; Hasimoto K; Itoh N; Yamashita S; Owen K
Hum Exp Toxicol; 1999 Jan; 18(1):38-45. PubMed ID: 10025367
[TBL] [Abstract][Full Text] [Related]
40. [A 4-week intravenous toxicity study of the active metabolite (NM394) of prulifloxacin (NM441) in rats followed by a 4-week recovery test].
Ishida S; Iketani M; Yamazaki S; Tamura K; Shindo Y; Iwakura K; Sumi N
J Toxicol Sci; 1996 Jun; 21 Suppl 1():131-48. PubMed ID: 8709157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
